UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer

Molecular and cellular endocrinology, 2018-02, Vol.462 (Pt A), p.56-63

2018

Volltextzugriff (PDF)

The role of TET-mediated DNA hydroxymethylation in prostate cancer

Molecular and cellular endocrinology, 2018-02, Vol.462 (Pt A), p.41-55

2018

Volltextzugriff (PDF)

The transcription intermediary factor 1β coactivates the androgen receptor

Journal of endocrinological investigation, 2013-10, Vol.36 (9), p.699-706

2013

Volltextzugriff (PDF)

Genomic analysis of localized prostate cancer identifies AZIN1 as driver of metastatic progression

European urology open science (Online), 2020-07, Vol.19, p.e1669

2020

Volltextzugriff (PDF)

The androgen receptor depends on ligand-binding domain dimerization for transcriptional activation

EMBO reports, 2021-12, Vol.22 (12), p.e52764-n/a

2021

Volltextzugriff (PDF)

The role of nuclear export in primary high-risk prostate cancer: A genomic analysis identifies XPO1 as potential therapeutic agent in high risk prostate cancer

European urology, 2021-06, Vol.79, p.S610

2021

Volltextzugriff (PDF)

Primary Structure Elements of Spider Dragline Silks and Their Contribution to Protein Solubility

Biochemistry (Easton), 2004-10, Vol.43 (42), p.13604-13612

2004

Volltextzugriff (PDF)

A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals

SLAS discovery, 2020-08, Vol.25 (7), p.695-708

2020

Volltextzugriff (PDF)

Description of the dimerization surface for the ligand-binding domain of the androgen receptor and its role in transcriptional control by agonists and antagonists

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e165-e166

2017

Volltextzugriff (PDF)

1073 Prostate cancer copy number score predicts metastatic disease

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e1073-e1073

2016

Volltextzugriff (PDF)

A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e837-e838

2017

Volltextzugriff (PDF)

Androgen Deprivation Modulates the Adrenocortical Stress Response

Endocrine Abstracts, 2023-11

2023

Volltextzugriff (PDF)

The role of TET1 and hydroxymethylation in high-risk prostate cancer

European urology supplements : official journal of the European Association of Urology, 2019-10, Vol.18 (8), p.e3097

2019

Volltextzugriff (PDF)

P33 - The role of TET1 and hydroxymethylation in high-risk prostate cancer

European urology supplements : official journal of the European Association of Urology, 2019-10, Vol.18 (8), p.e3097-e3097

2019

Volltextzugriff (PDF)

Androgen Insensitivity Syndrome can be due to a dimerization defect in the androgen receptor

Endocrine Abstracts, 2019-10

2019

Volltextzugriff (PDF)

Genomic analysis of localised prostate cancer identifies AZIN1 as driver of metastatic progression

European urology supplements : official journal of the European Association of Urology, 2019-10, Vol.18 (8), p.e3127

2019

Volltextzugriff (PDF)

P60 - Genomic analysis of localised prostate cancer identifies AZIN1 as driver of metastatic progression

European urology supplements : official journal of the European Association of Urology, 2019-10, Vol.18 (8), p.e3127-e3127

2019

Volltextzugriff (PDF)

Genomic analysis of localized high-risk prostate cancer identifies XPO1 as a potential driver mechanism of metastatic progression

European urology supplements : official journal of the European Association of Urology, 2019-11, Vol.18 (11), p.e3514

2019

Volltextzugriff (PDF)

P086 - Genomic analysis of localized high-risk prostate cancer identifies XPO1 as a potential driver mechanism of metastatic progression

European urology supplements : official journal of the European Association of Urology, 2019-11, Vol.18 (11), p.e3514-e3514

2019

Volltextzugriff (PDF)

P39 - Drivers and therapeutic vulnerabilities in AR indifferent anti-androgen resistant prostate cancer cells

European urology supplements : official journal of the European Association of Urology, 2019-10, Vol.18 (8), p.e3104-e3104

2019

Volltextzugriff (PDF)

Drivers and therapeutic vulnerabilities in AR indifferent anti-androgen resistant prostate cancer cells

European urology supplements : official journal of the European Association of Urology, 2019-10, Vol.18 (8), p.e3104

2019

Volltextzugriff (PDF)

Physiological relevance of LBD-dimerization of the androgen receptor

Endocrine Abstracts, 2018-10

2018

Volltextzugriff (PDF)

57 - Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through regulation of collagen expression

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e84-e84

2018

Volltextzugriff (PDF)

Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through regulation of collagen expression

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e84

2018

Volltextzugriff (PDF)

483 - A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e837-e838

2017

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer

The role of TET-mediated DNA hydroxymethylation in prostate cancer

The transcription intermediary factor 1β coactivates the androgen receptor

Genomic analysis of localized prostate cancer identifies AZIN1 as driver of metastatic progression

The androgen receptor depends on ligand-binding domain dimerization for transcriptional activation

The role of nuclear export in primary high-risk prostate cancer: A genomic analysis identifies XPO1 as potential therapeutic agent in high risk prostate cancer

Primary Structure Elements of Spider Dragline Silks and Their Contribution to Protein Solubility

A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals

Description of the dimerization surface for the ligand-binding domain of the androgen receptor and its role in transcriptional control by agonists and antagonists

1073 Prostate cancer copy number score predicts metastatic disease

A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population

Androgen Deprivation Modulates the Adrenocortical Stress Response

The role of TET1 and hydroxymethylation in high-risk prostate cancer

P33 - The role of TET1 and hydroxymethylation in high-risk prostate cancer

Androgen Insensitivity Syndrome can be due to a dimerization defect in the androgen receptor

Genomic analysis of localised prostate cancer identifies AZIN1 as driver of metastatic progression

P60 - Genomic analysis of localised prostate cancer identifies AZIN1 as driver of metastatic progression

Genomic analysis of localized high-risk prostate cancer identifies XPO1 as a potential driver mechanism of metastatic progression

P086 - Genomic analysis of localized high-risk prostate cancer identifies XPO1 as a potential driver mechanism of metastatic progression

P39 - Drivers and therapeutic vulnerabilities in AR indifferent anti-androgen resistant prostate cancer cells

Drivers and therapeutic vulnerabilities in AR indifferent anti-androgen resistant prostate cancer cells

Physiological relevance of LBD-dimerization of the androgen receptor

57 - Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through regulation of collagen expression

Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through regulation of collagen expression

483 - A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population

Suchergebnisse filtern